Invion Limited logo — Leading the global clinical development of the Photosoft™ te...

Invion Limited

Leading the global clinical development of the Photosoft™ technology for the treatment of cancers.

Founded 2012 Australia Australia 10 employees Biotechnology

General Information

Company Name Invion Limited
Founded Year 2012
Location Australia Australia +1
Founders / Decision Makers
Dr Greg Collier  — Managing Director & Chief Executive Officer
Employees 10
Industries Biotechnology
Social

Get notified when Invion Limited moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Invion Limited

Invion Limited is a clinical-stage life-sciences company founded in 2012, focused on leading the global clinical development of the Photosoft™ technology for cancer treatment. The company has been appointed the exclusive distributor and licensee in Australia and New Zealand of Photosoft™, a cutting-edge technology developed by The Cho Group, a Hong Kong-based organization with a successful track record in commercializing advanced technologies. Notably, The Cho Group is funding the research and clinical trials of Photosoft™ through an R&D services agreement with Invion. Furthermore, Invion has formed a strategic alliance with the esteemed Hudson Institute of Medical Research in Australia for the Photosoft™ research program. As a player in the biotechnology industry, Invion aims to leverage this collaboration to advance the clinical development of Photosoft™. The company's focus on revolutionary cancer treatment through cutting-edge technology positions it as an attractive opportunity for venture capital firms seeking investment prospects in the biotechnology sector. Invion's collaboration with The Cho Group and the alliance with Hudson Institute of Medical Research underscores its potential for growth and innovation in cancer treatment.

Taxonomy: clinical development, cancer treatment, technology licensing, R&D funding, medical research, clinical trials, global development strategy, pharmaceutical drug development, FDA-regulated, respiratory diseases, autoimmune diseases

No funding data available for Invion Limited yet.

Get notified when Invion Limited raises funding

Invion Limited Alternatives & Competitors

Invion Limited vs

The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the N...

36 employees
Invion Limited vs

Public Powered Cancer Research

60 employees
Invion Limited vs
EVICR.net
EVICR.net Portugal

Dedicated to perform multinational clinical research in ophthalmology with the highest standards of...

3 employees
Health Care, Health and Wellness

FAQ About Invion Limited

Leading the global clinical development of the Photosoft™ technology for the treatment of cancers.
Invion Limited was founded in 2012.
Invion Limited is headquartered in Australia.
Invion Limited operates in the following industries: Biotechnology.
Invion Limited has approximately 10 employees.
Top alternatives and competitors to Invion Limited include Immune Tolerance Network, SWOG Cancer Research Network, EVICR.net, Tiba Biotech, Chiropractic Knowledge Hub. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Invion Limited and Immune Tolerance Network are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Invion Limited and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy